Experience

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $108.6 million initial public offering of 6,785,000 shares of common…

Davis Polk advised the dealer managers in connection with the cash tender offers by General Electric Company (“GE”) to purchase any and all of certain of its outstanding U.S. dollar, euro…

Davis Polk is advising FormFactor, Inc. in connection with its acquisition of Cascade Microtech, Inc. for a total equity value of approximately $352 million in cash and stock consideration…

Davis Polk advised Hangzhou Hikvision Digital Technology Co., Ltd. (“Hikvision”) in connection with its debut issue of €400 million 1.25% notes due 2019. The notes are to be listed on the…

Davis Polk advised the joint bookrunning managers in connection with BPCE’s Section 3(a)(2) offering of $750 million 2.650% notes due 2021 under BPCE’S $25 billion Medium Term Note Program…

Davis Polk is advising the dealer managers on ConAgra Foods’ cash tender offers to purchase up to $1.4 billion aggregate principal amount of its 5.819% senior notes due 2017, its 7.000%…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 29,884,393 shares of Class B common stock of Molson Coors Brewing Company (…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.250% U.S. dollar bonds due 2019 issued by Export Development Canada. Export…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Novavax, Inc. of an aggregate principal amount of …

Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by Abbott Laboratories. The transaction is subject to the approval of…